Cargando…

Drug repositioning in epilepsy reveals novel antiseizure candidates

OBJECTIVE: Epilepsy treatment falls short in ~30% of cases. A better understanding of epilepsy pathophysiology can guide rational drug development in this difficult to treat condition. We tested a low‐cost, drug‐repositioning strategy to identify candidate epilepsy drugs that are already FDA‐approve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brueggeman, Leo, Sturgeon, Morgan L., Martin, Russell M., Grossbach, Andrew J., Nagahama, Yasunori, Zhang, Angela, Howard, Mathew A., Kawasaki, Hiroto, Wu, Shu, Cornell, Robert A., Michaelson, Jacob J., Bassuk, Alexander G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6389756/ https://www.ncbi.nlm.nih.gov/pubmed/30847362 http://dx.doi.org/10.1002/acn3.703

Ejemplares similares

The opioid antagonist naltrexone decreases seizure‐like activity in genetic and chemically induced epilepsy models
por: Sturgeon, Morgan L., et al.
Publicado: (2021)

Author Correction: Forecasting risk gene discovery in autism with machine learning and genome-scale data
por: Brueggeman, Leo, et al.
Publicado: (2020)

Forecasting risk gene discovery in autism with machine learning and genome-scale data
por: Brueggeman, Leo, et al.
Publicado: (2020)

Response to subsequent antiseizure medications after first antiseizure medication failure in newly diagnosed epilepsy
por: Hersi, Hire, et al.
Publicado: (2022)

Epilepsy, Antiseizure Therapy, and Sleep Cycle Parameters
por: Shvarts, Vladimir, et al.
Publicado: (2013)

Drug-resistant epilepsy development following stem cell transplant and cyclosporine neurotoxicity induced seizures: Case report in an adult and analysis of reported cases in the literature
por: Vesole, Adam S., et al.
Publicado: (2018)

Identification of New Antiseizure Medication Candidates in Preclinical Animal Studies
por: Yang, Chih-Sheng, et al.
Publicado: (2023)

Influence of Different Antiseizure Medications on Vascular Risk Factors in Children with Epilepsy
por: Mahrous, Doaa M., et al.
Publicado: (2022)

Risk of sudden unexpected death in epilepsy (SUDEP) with lamotrigine and other sodium channel‐modulating antiseizure medications
por: Nightscales, Russell, et al.
Publicado: (2023)

Research Progress on the Effect of Epilepsy and Antiseizure Medications on PCOS Through HPO Axis
por: Li, Shuang, et al.
Publicado: (2021)

Brain tumor related epilepsy: pathophysiological approaches and rational management of antiseizure medication
por: Seidel, Sabine, et al.
Publicado: (2022)

Efficacy, Tolerability, and Retention of Antiseizure Medications in PRRT2-Associated Infantile Epilepsy
por: Döring, Jan H., et al.
Publicado: (2022)

Antiseizure medication treatment pathways for US Medicare beneficiaries with newly treated epilepsy
por: Terman, Samuel W., et al.
Publicado: (2022)

Therapeutic Potential of Mesenchymal Stem Cells in the Treatment of Epilepsy and Their Interaction with Antiseizure Medications
por: Tesiye, Maryam Rahimi, et al.
Publicado: (2022)

Effect of clinical features on antiseizure medication doses in patients with newly diagnosed epilepsy
por: Hersi, Hire, et al.
Publicado: (2023)

First‐line levetiracetam versus enzyme‐inducing antiseizure medication in glioma patients with epilepsy
por: van der Meer, Pim B., et al.
Publicado: (2022)

Genome-wide DNA methylation comparison between live human brain and peripheral tissues within individuals
por: Braun, Patricia R., et al.
Publicado: (2019)

Effectiveness of Antiseizure Medication Triple Therapy in Patients With Glioma With Refractory Epilepsy: An Observational Cohort Study
por: van der Meer, Pim B., et al.
Publicado: (2023)

Teratogenicity and Antiseizure Medications
por: Meador, Kimford
Publicado: (2020)

Antiseizure medications and pregnancy
por: Moores, Ginette, et al.
Publicado: (2021)

Neuropharmacology of Antiseizure Drugs
por: Hakami, Tahir
Publicado: (2021)

Screening of prototype antiseizure and anti‐inflammatory compounds in the Theiler's murine encephalomyelitis virus model of epilepsy
por: Metcalf, Cameron S., et al.
Publicado: (2021)

Association between addressing antiseizure drug side effects and patient-reported medication adherence in epilepsy
por: Moura, Lidia M V R, et al.
Publicado: (2016)

Antiseizure medications for post‐stroke epilepsy: A real‐world prospective cohort study
por: Tanaka, Tomotaka, et al.
Publicado: (2021)

Does Adjustment of Antiseizure Medication Regimen after Failed Epilepsy Surgery Improve Outcomes?
por: Wu, Yuxin, et al.
Publicado: (2023)

Adverse Event Profiles of Antiseizure Medications and the Impact of Coadministration on Drug Tolerability in Adults with Epilepsy
por: Willems, Laurent M., et al.
Publicado: (2023)

Excessively increased thalamocortical connectivity and poor initial antiseizure medication response in epilepsy patients
por: Zhong, Jiyuan, et al.
Publicado: (2023)

Antiseizure medications for idiopathic generalized epilepsies: a systematic review and network meta-analysis
por: Chu, Hongyuan, et al.
Publicado: (2023)

Real‐world antiseizure medication treatment outcomes in drug‐resistant focal epilepsy patients
por: Hatoum, Hind T., et al.
Publicado: (2023)

Incidence of and predictors for antiseizure medication gaps in Medicare beneficiaries with epilepsy: a retrospective cohort study
por: Terman, Samuel W., et al.
Publicado: (2022)

The Clinical Characteristics of New-Onset Epilepsy in the Elderly and Risk Factors for Treatment Outcomes of Antiseizure Medications
por: Qi, Jing, et al.
Publicado: (2022)

Trends in Prescribing of Antiseizure Medications in South Korea: Real-World Evidence for Treated Patients With Epilepsy
por: Kang, Kyung Wook, et al.
Publicado: (2022)

Evaluation of antiseizure medications including zonisamide in feline idiopathic epilepsy at a referral hospital in Japan
por: Yoshida, Shino, et al.
Publicado: (2023)

Efficacy and tolerability of antiseizure drugs
por: Hakami, Tahir
Publicado: (2021)

Development of an antiseizure drug screening platform for Dravet syndrome at the NINDS contract site for the Epilepsy Therapy Screening Program
por: Pernici, Chelsea D., et al.
Publicado: (2021)

Spreading depression as an innate antiseizure mechanism
por: Tamim, Isra, et al.
Publicado: (2021)

Differences between men and women in response to antiseizure medication use and the likelihood of developing treatment resistant epilepsy
por: Cepeda, M. Soledad, et al.
Publicado: (2022)

Decreased serum concentrations of antiseizure medications in children with drug resistant epilepsy following treatment with ketogenic diet
por: Pedersen, Sigrid, et al.
Publicado: (2023)

Optimizing treatment persistence in epilepsy: a comparative analysis of combined antiseizure medications with different mechanisms of action
por: Chang, Chun-Wei, et al.
Publicado: (2023)

Antiseizure Medications in Alzheimer’s Disease from Preclinical to Clinical Evidence
por: Bosco, Francesca, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_avi93eplrho63qi6g0ua08hd64